David A. Siegel Teva Pharmaceutical Industries LTD Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Two Sigma Advisers, LP holds 232,100 shares of TEVA stock, worth $4.51 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
232,100
Previous 331,500
29.98%
Holding current value
$4.51 Million
Previous $5.1 Million
23.67%
% of portfolio
0.01%
Previous 0.01%
Shares
30 transactions
Others Institutions Holding TEVA
# of Institutions
653Shares Held
659MCall Options Held
30.1MPut Options Held
16.4M-
Black Rock Inc. New York, NY43MShares$835 Million0.02% of portfolio
-
Menora Mivtachim Holdings Ltd.38.5MShares$748 Million3.78% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E938.3MShares$745 Million36.86% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L337.8MShares$734 Million5.98% of portfolio
-
Phoenix Holdings Ltd. Givatayim, L337.8MShares$733 Million8.62% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $21.6B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...